Covid-19: why mix and match vaccines?

The Com-Cov trial run by the Oxford Vaccine Group in the UK will be testing the efficacy and safety of a ‘mix and match’ approach to immunisation. By giving some participants either the Pfizer/BioNTech or Oxford/AstraZeneca vaccine, and a second dose of the other, the trial aims to find out if combining different jabs offers sufficient protection. Sarah Boseley speaks to Dr Peter English about where this technique has been used in the past, why it could be beneficial, and how mixing vaccines actually works. Help support our independent journalism at theguardian.com/sciencepod

More from Science Weekly

  1. 15:58Has the pandemic changed our sleep habits? – podcastApr 22, 2021
  2. 20:41Why is it so bad being a night owl? – podcastApr 20, 2021
  3. 17:13Do humans respond differently to screams of pleasure and pain? – podcastApr 15, 2021
  4. 25:50Covid-19: what’s going on with the AstraZeneca vaccine?Apr 13, 2021
  5. 14:04Covid-19: how does it cause heart damage?Apr 08, 2021
  6. 22:38Why has the African elephant been split into two species?Apr 06, 2021
  7. 26:16Should we determine species through DNA? (part two)Apr 01, 2021
  8. 25:37Why is it hard to get our head around fungi? (part one)Mar 30, 2021
  9. 19:15You can't bullshit a bullshitter, or can you?Mar 25, 2021
  10. 27:40Covid-19: what happens next?Mar 23, 2021